Dipeptidyl peptidase-4 inhibitors and cardiovascular and...

  • Main
  • 2019 / 04
  • Dipeptidyl peptidase-4 inhibitors and cardiovascular and...
Diabetes and Vascular Disease Research 2019 / 04

Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial?

Hanssen, Nordin MJ, Jandeleit-Dahm, Karin AM
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes and Vascular Disease Research
DOI:
10.1177/1479164119842339
Date:
April, 2019
File:
PDF, 127 KB
english, 2019
Conversion to is in progress
Conversion to is failed